Report outlines innovative breast cancer rehabilitation model

Key points
- A new supplement in the journal Cancer outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise.
- The supplement says the current model of care for people with breast cancer focuses on treatment of the disease, followed by ongoing surveillance to detect recurrence.
- The PSM is ultimately coordinated with disease treatment from diagnosis through follow-up to create a more comprehensive, multi-disciplinary approach to survivorship care.
- A panel of experts proposes a prospective surveillance model (PSM) that could reduce the incidence and severity of breast cancer treatment-related physical impairments.
A new supplement in the journal Cancer outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise. A panel of experts proposes a prospective surveillance model (PSM) that could reduce the incidence and severity of breast cancer treatment-related physical impairments. The model was developed over the past year by a panel of internationally known experts, with the support of the American Cancer Society and input from national healthcare professional organizations and advocacy groups.
The supplement says the current model of care for people with breast cancer focuses on treatment of the disease, followed by ongoing surveillance to detect recurrence. That approach, says the supplement, lacks attention to patients' physical and functional well-being. Breast cancer patients experience common impairments including pain, fatigue, upper extremity dysfunction, lymphedema, weakness, joint arthralgia, neuropathy, weight gain, cardiovascular effects, and osteoporosis. And even when these impairments lead to functional limitation, rehabilitation referral is lacking.
The supplement points to evidence that supports the implementation of a prospective surveillance model for early identification and treatment of physical impairments that may prevent or mitigate many of these functional concerns as well as provide a venue to point patients towards exercise and other health promoting activities. The goals of the model are to promote surveillance for common breast cancer-related physical impairments and functional limitations, to provide education to facilitate early identification of impairments, to introduce rehabilitation and exercise intervention when physical impairments are identified, and to promote and support physical activity and exercise behaviors through the trajectory of disease treatment and survivorship.
The PSM is ultimately coordinated with disease treatment from diagnosis through follow-up to create a more comprehensive, multi-disciplinary approach to survivorship care. The purpose of the supplement is to invite consideration of the model as a means to achieve reduced impairment, improved function, and increased participation in exercise.
###
Support for this meeting and supplement was provided by the American Cancer Society through The Longaberger Company®, a direct selling company offering home products including handcrafted baskets made in Ohio, and the Longaberger Horizon of Hope® Campaign, which provided a grant to the American Cancer Society for breast cancer research and education.
Participants:
Kathryn H. Schmitz, PhD, MPH, FACSM
University of Pennsylvania School of Medicine
Abramson Cancer Center
Nicole L. Stout, MPT, CLT-LANABreast Care CenterWalter Reed National Military Medical Center
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsUGR scientists patent an effective drug for treating breast, colon, and skin cancers
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on…
21 October 2015
GuideDecoding the microbial signature of aggressive form of breast cancer
Cancer is a result of normal cellular functions going wildly awry on a genetic level. That fact has been known for some time, but increasing evidence is showing that the human microbiome, the diverse population of…
16 October 2015
NewsAdoption of streamlined breast cancer treatment has stagnated, study finds
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning…



